article thumbnail

Health Provider News

Hall Render

A doctor shares the latest HHS opens probe into UnitedHealth’s cybersecurity as hack fallout continues HHS sends letter to healthcare leaders on Change cyberattack Hospitals face rising labor bill How 4 major payers have been affected by Change Healthcare attack Nonprofit hospitals still have negative outlook, but Fitch projects ‘better times’ Operating (..)

article thumbnail

Health Provider News

Hall Render

Louis nursing home endangered residents, report says Man pleads guilty to stabbing employee inside Missouri ASC A Missouri nursing home shut down suddenly. A new report offers insight into the ensuing confusion Rep. Cori Bush joins St.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News

Hall Render

NATIONAL 988 suicide hotline adds support for American Sign Language 3 Takeaways from Physician Compensation Trends Adventist Health completes merger with Montebello’s ailing Beverly Hospital AHA-supported bill to protect health care workers introduced in Senate AHA weighs in on CMS’ proposed ASC payment system AHA submits comments on CY 2024 (..)

article thumbnail

Health Provider News

Hall Render

into cutting opioids in hospitals ISU and University of Utah partnership aims to combat Idaho’s mental health crisis Presbyterian-UnityPoint merger moves forward St. Mississippi Dept.

article thumbnail

Health Provider News

Hall Render

1 CMS final rule boosts Medicare hospice payments by 3.1% News Ranking DC DC-area hospitals ranked among best in the nation DC Health releases results of investigation into nursing home after 7News story about medication errors Inova Fairfax tops new U.S. To Address SDOH Needs U.S.

article thumbnail

A Health-Heavy State of the Union

Kaiser Health News

The FDA is at the center of the abortion pill case, which challenges its approval of the drug decades ago and could set a precedent for legal challenges to the approval of other drugs. While they do plan to appeal the ruling should the FDA lose, the upheaval that could happen in the meantime can’t really be overstated.